×

RNS Number : 2843N

Intuitive Investments Group plc

29 January 2021

 

Intuitive Investments Group plc

("IIG" or the "Company")

 

Portfolio company BioQ Pharma receives CE mark

EU approval for BioQ's next generation medication dispenser

 

Intuitive Investments Group plc (AIM: IIG), a closed-end investment company focussed on the life sciences sector, announces that its portfolio company, BioQ Pharma Incorporated ("BioQ"), has received CE mark approval for its single-use medication dispenser, the OneDose ReadyfusOR Gen2.

 

The OneDose ReadyfusOR Gen2 is the second generation of BioQ's original OneDose ReadyfusOR infusion system and was developed to further improve patient convenience. The new system is smaller and lighter than the original product. For the full announcement, visit: https://bioqpharma.com/news/article_20210127

 

BioQ is a well-established, commercial-stage, medical device and pharmaceutical company, addressing the infusible drugs market. BioQ's proprietary InveniousTM platform comprises a "connect-and-go" drug-device system combination, which can be utilised to improve the delivery of infusible medicines. The key benefits of the platform include reduced cost and complexity compared to current infusion techniques. Further information on BioQ can be found at the company's website: www.bioqpharma.com .

 

On 21 January 2021, IIG announced its investment of US$1 million by way of unsecured convertible loan notes in BioQ, the Company's second investment from its pipeline of opportunities following its successful IPO in December 2020.

 

 

For further information, please contact:

 

Intuitive Investments Group plc	www.iigplc.com
David Evans	Via Walbrook PR
Strand Hanson Limited – Nominated Adviser	+44 (0)20 7409 3494
James Harris / James Dance / James Bellman
Turner Pope Investments (TPI) Ltd – Broker	+44 (0)20 3657 0050
Ben Turner / James Pope / Andrew Thacker
Walbrook PR Limited – Media & Investor Relations	+44 (0)20 7933 8780 or [email protected]
Paul McManus	+44 (0) 7980 541 893

 

 

About Intuitive Investments Group plc

 

The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRABIGDBIUDDGBI

Close

×

RNS Number : 3778M

Intuitive Investments Group plc

21 January 2021

 

 

Intuitive Investments Group plc

("IIG" or the "Company")

Investment in BioQ Pharma

Intuitive Investments Group plc (AIM:IIG), a closed-end investment company focussed on the life sciences sector, is pleased to announce its investment of US$1 million by way of unsecured convertible loan notes ("CLNs") in BioQ Pharma Incorporated ("BioQ").

BioQ is a well-established, commercial-stage, medical device and pharmaceutical company, addressing the infusible drugs market. BioQ's proprietary InveniousTM platform comprises a "connect-and-go" drug-device system combination, which can be utilised to improve the delivery of infusible medicines.  BioQ's platform includes a bespoke unit-dose delivery solution for infusible drugs, whereby a diluent delivery system and administration line are combined in one self-contained, ready-to-use presentation. The key benefits of the platform include reduced cost and complexity compared to current infusion techniques. Further information on BioQ can be found at the company's website: www.bioqpharma.com .

IIG's investment in BioQ consists of US$1 million of CLNs maturing on 1 November 2021. The terms of the CLN include a coupon of 10% that is accrued and paid on conversion or repayment, warrant coverage, and provisions for conversion into new equity at the time of a qualifying future fundraise (at a 35 per cent. discount to the price of such fundraise) or at maturity.

BioQ is the Company's second investment from its pipeline of opportunities, and follows its successful IPO in December 2020.

David Evans personally invested US$75,000 in Bio Q's Series B funding round in 2009 which is less than an 0.5% interest in the company. Accordingly, David Evans did not vote as a member of the Board of IIG approving the transaction.  

In the nine months ended 30 September 2020, BioQ made a net loss of US$5.9million and, as at 30 September 2020, had net liabilities of approximately US$32 million.

David Evans, Chairman of IIG, said:

"We are hugely impressed by BioQ and what Josh Kriesel and the BioQ team have built in the US and Europe. We strongly believe the adoption by the healthcare providers of BioQ's " Pharmacy in a Box" which is also a "connect-and-go" delivery system will continue to accelerate in the near term. Our investment demonstrates IIG's ability to act quickly and opportunistically when compelling opportunities arise."

 

For further information, please contact:

 

Intuitive Investments Group plc
David Evans	Via Walbrook PR
Strand Hanson Limited – Nominated Adviser	+44 (0) 20 7409 3494
James Harris / James Dance / James Bellman
Turner Pope Investments (TPI) Ltd – Broker	+44 (0) 20 3657 0050
Ben Turner / James Pope / Andrew Thacker
Walbrook PR Limited – Media & Investor Relations	+44 (0)20 7933 8780 or [email protected]
Paul McManus	+44 (0) 7980 541 893

 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

 

About Intuitive Investments Group plc

 

The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCDBLFLFFLLBBD

Close

×

RNS Number : 3738M

Image Scan Holdings PLC

21 January 2021

 

REACH – This is a non-regulatory announcement.

21 January 2021

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

CONTRACT TO SUPPLY PORTABLE X-RAY SYSTEMS TO THE ROYAL AIR FORCE

 

Image Scan (AIM: IGE), specialists in the field of X-ray imaging for the security and industrial inspection markets, announces the award of a contract to supply three portable X-ray scanning systems to the Royal Air Force.

 

The systems to be supplied are the ThreatScan®-LSC, a combination package including a large format ThreatScan®-LS1 panel, a compact ThreatScan®-LS3 panel with back-pack, a tablet PC imaging station and the I-Gen generator. This combination system provides great deployment flexibility for different threat scenarios.

 

The award is the Company's first contract with the RAF.

 

Bill Mawer, Chairman and Chief Executive Officer of Image Scan commented: "I am delighted by this contract award. It provides a key reference with the UK Government that should both help us to achieve further UK sales and support our international marketing campaigns. The ThreatScan®-LSC 'Combi' system is our highest value portable X-ray package, and we look forward to further sales of this configuration."

 

For further information on the Company, please visit:   www.ish.co.uk   and for further information on its products, please visit:   www.3dx-ray.com

 

Enquiries:
Image Scan Holdings plc William Mawer, Chairman and Chief Executive Officer Sarah Atwell King, Finance Director and Company Secretary	Tel: +44 (0) 1509 817 400 [email protected]

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAURRBRAAUAUAR

Close

×

RNS Number : 2326M

DeepMatter Group PLC

20 January 2021

 

20 January 2021

 

DeepMatter Group plc

("DeepMatter", the "Company" or "the Group")

 

DeepMatter subsidiary signs data licensing agreement with the Life Science business of Merck

DeepMatter Group plc, the AIM-quoted company focusing on digitising chemistry, is pleased to announce that one of its wholly owned subsidiaries has entered into a multi-year, limited-use data licensing agreement with the Life Science business of Merck to provide proprietary chemical structure and reaction data content to Merck's selected application.

Merck, a leading science and technology company, operates across Healthcare, Life Science and Performance Materials.  The terms of the data license agreement have not been disclosed.

 

Mark Warne, CEO of DeepMatter commented : "We are delighted to have entered into this license with Merck, a company dedicated to making research and biotech simpler, faster and safer."

 

 

For more information, please contact:

 

DeepMatter Group plc	T: 0141 548 8156
Mark Warne, Chief Executive Officer
Canaccord Genuity Limited (Nominated Advisor and Broker)	T:  020 7523 8000
Bobbie Hilliam / Angelos Vlatakis
Alma PR	T: 020 3405 0205
Caroline Forde / Harriet Jackson / Kieran Breheny	[email protected]

 

About DeepMatter Group plc  

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. It has developed and is commercialising data rich platform technologies, including software and laboratory hardware, focused on applications to improve R&D productivity and discovery using Machine Learning / Artificial Intelligence.  

DeepMatter's technologies allow chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. They are designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.  

About Merck

Merck, a leading science and technology company, operates across Healthcare, Life Science and Performance Materials. Around 57,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of €16.2 billion in 66 countries.

 

www.merckgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTKKLFFFFLBBBE

Close

×

RNS Number : 4343L

Biome Technologies PLC

13 January 2021

 

REACH

13 January 2021

 

Biome Technologies plc

("Biome", the "Group" or the "Company")

Biome successfully completes feasibility phase of biodegradable tree shelter project

 

Biome's Bioplastics division ( www.biomebioplastics.com ) announces the successful completion of its three-month feasibility project to develop and test a new generation of biodegradable tree shelters to be manufactured from the Company's bioplastics.

Tree shelters protect young trees and bushes from predation by animals. They are a well-proven and economic route to limiting losses in the first five years of a tree's life. Traditionally made from oil-based and non-biodegradable plastics, the majority of such shelters are never collected and eventually litter the environment with microplastics.

In the UK, around 45 million trees are planted each year, most of those using non-biodegradable tree shelters for protection, with an estimated 2,500 tons of persistent plastics ending up annually in the natural environment after use. Plans to significantly increase tree planting as part of the UK's drive to mitigate climate change will exacerbate these problems.

The initial feasibility project has allowed the Company to explore the performance of a variety of bioplastic materials in this application and culminated in the manufacture of prototypes at Biome's customer's premises.

The polymers that Biome are using in this project are bio-based and biodegradable. Some are novel and represent some of the results of over six years and £6.5 million of directed investment in research collaboration between Biome and a number of the UK's leading universities. The development of biodegradable tree shelters is the first potential commercial application arising from this collaborative group's endeavours. The polymers used in this particular project are partly based on furandicarboxylic acid (FDCA) monomeric building blocks. More information regarding the processes for the formation of FDCA can be found on the Company's website, https://biomebioplastics.com/industrial-biotechnology/ .

This feasibility project was supported by a funding contract between Biome and the UK Government's agency, Innovate UK, as part of the Sustainable Innovation Fund (SBRI Phase 1). The Company has tendered for a further contract under SBRI Phase 2 with a view to starting large-scale field trials of novel biodegradable tree shelters during 2021.

To provide investors with more details on the scientific approach to this project and its future path to prospective commercialisation, the Company has commissioned a short explanatory video that can be viewed here: https://vimeo.com/494238613 .

 

-Ends-

 

For further information please contact: Biome Technologies plc

Paul Mines, Chief Executive Officer

Donna Simpson-Strange, Company Secretary

[email protected]

Tel: +44 (0) 2380 867 100

www.biometechnologiesplc.com

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

Tel: +44 (0) 20 3328 5656

www.allenbycapital.com

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com

www.biomebioplastics.com   and  www.thinkbioplastic.com  

www.stanelcorftechnologies.com

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRADKBBQNBKDDDD

Close

×

RNS Number : 6830K

Shearwater Group PLC

06 January 2021

 

6 January 2021

 

 

SHEARWATER GROUP PLC

("Shearwater", or the "Group")

 

Contract Win

 Brookcourt Solutions signs five year supply agreement with global retailer

 

Shearwater Group plc, the organisational resilience group, announces that its group company, Brookcourt Solutions Limited ("Brookcourt"), has secured a five-year supply agreement with a global fashion retailer, headquartered in New York.

 

The first contract to be delivered under the supply agreement encompasses the delivery of a secure ID-authenticated printing solution as well as a 12-month maintenance and service contract, for use within ten European countries across 17 sites. The value of the first contract is £860 ,000, of which the majority is expected to be recognised in the current full year. This contract win underpins the Group's current full year forecasts, with the supply agreement having the potential to deliver further revenue opportunities in future years.

 

Brookcourt presented a secure ID-authenticated printing solution that was selected by the client due to its superior technology and enhanced security features, safeguarding important documentation which is never left unattended but can be printed securely when required. This solution ensures that the global retailer is protected by very high security standards, whilst the implementation of the new technology will also result in improved efficiencies and cost savings for the client.

 

Phil Higgins, Group Chief Executive Officer of Shearwater, commented:

"We are pleased to have secured this contract win with a successful global retailer. Our new client appreciates the importance of maintaining vigorous security standards in order to protect its business.

 

The supply agreement demonstrates Brookcourt's ability to leverage its deep understanding of best-in-class technologies in order to deploy robust, effective and cost-efficient solutions for complex businesses such as this which span numerous markets."

 

Enquiries:

 

Shearwater Group plc David Williams Phil Higgins	www.shearwatergroup.com c/o Alma PR
Cenkos Securities plc – NOMAD and Joint Broker Max Hartley / Ben Jeynes – NOMAD Julian Morse / Michael Johnson – Sales	+44 (0) 20 7397 8900
Berenberg – Joint Broker  Matthew Armitt / Mark Whitmore	+44 (0) 20 3207 7800
Alma PR Susie Hudson / Caroline Forde / Harriet Jackson	[email protected]  +44 (0) 20 3405 0205

 

 

About Shearwater Group plc

 

Shearwater Group plc is an award-winning organisational resilience group that provides cybersecurity, advisory and managed security services to help assure and secure businesses in a connected global economy.

 

The Group's comprehensive cybersecurity solutions and services maintain trust between users, assure the protection of information assets and critical infrastructure, and support organisations' operational effectiveness. Its capabilities include identity and access management and data security, cybersecurity solutions and managed security services, and security governance, risk and compliance.

 

The Group is headquartered in the UK, serving customers across the globe who are active in a broad spectrum of industries.

 

Shearwater shares are listed on the London Stock Exchange's AIM under the ticker "SWG".  For more information, please visit www.shearwatergroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTDKPBKFBKDQDK

Close

×

Neville Registrars is delighted to welcome Vector Capital plc as the newest addition to its list of client companies.

Vector Capital, together with its Subsidiaries, is a commercial lending group that offers secured loans primarily to businesses located in the United Kingdom.

Further information can be found on the Company's website: https://vectorcapital.co.uk/

Close

×

Neville Registrars is delighted to welcome One Heritage Group Plc as the newest addition to its list of client companies.

One Heritage Group is a property development and investment management company, focusing on the residential sectors primarily in the North West rental market, seeking out value and maximising opportunities for its investors.

Further information can be found on the Company's website: https://www.one-heritageplc.com/

Close

×

One Heritage Group plc (OHG) One Heritage Group plc: Admission to Trading on the London Stock Exchange and First Day of Dealings 23-Dec-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.   23 December 2020 ONE HERITAGE GROUP PLC Admission to Trading on the London Stock Exchange and First Day of Dealings One Heritage Group PLC ("One Heritage"), the UK based residential developer, is pleased to announce that One Heritage's entire issued ordinary share capital has today been admitted to the standard listing segment of the Official List of the London Stock Exchange's Main Market for listed securities under the ticker "OHG". One Heritage, has successfully raised £930,000 (before expenses) via a combination of a subscription and a placing with Hybridan of a total 9.3 million new Ordinary Shares with investors at a price of 10 pence per Ordinary Share (the "Placing Price"). One Heritage's market capitalisation at the Placing Price on admission will be £3.0 million. Group activities The Group undertakes development and re-development of new and existing buildings ("Development Activities") to create self-contained residential apartments, and the refurbishment of existing residential properties ("Refurbishment Activities") to create Co-living accommodation. The Group will act as its own principal or as a development manager on behalf of third-party investors for both Development Activities and Refurbishment Activities. The Group also undertakes letting and property and facilities management ("L&PFM") services for these products. All Group activities are undertaken solely in the UK. Developed or refurbished properties owned by the Group will then be sold or retained. Co-living properties will be sold on the open market primarily to investors through the Group's marketing network in Hong Kong. Schemes of self-contained apartments will be sold to investors through the Group's marketing network in Hong Kong or through a forward sale agreement to institutional investors. Business strategy and execution The Group will undertake its activities by deploying a design approach and L&PFM service levels that are attractive to younger socially mobile professionals and those seeking more flexible living arrangements. The Directors consider that the product range of self-contained apartments and Co-living accommodation, allied with high quality L&PFM services, will provide a broad appeal to this demographic group. The initial geographical focus of the Group's activities will be primarily high demand areas in the North West of England. This demand will be underpinned by strong economic and employment growth in Manchester, which is forecast to be one of the UK's strongest performing cities over the next few years according to Ernst & Young LLP's Regional Economic Forecast.  Data from the Office of National Statistics, predicts that the growth in the number of households in Greater Manchester between 2020 and 2038 will be 10.4 per cent. compared to 7.4 per cent. over the previous 10 years.  This increased demand is twinned with structural undersupply of housing which, over the last 10 years, has shown that the number of net new dwellings is 15 per cent. less than the growth in households with the Greater Manchester Economic Forecasting Model showing an increase in employment of 10.7 per cent. over the same period. The Group will focus on edge of city centre locations where there are good transport links or where there is a major local employer to underpin demand allowing a high-quality housing product to be delivered at a competitive price point. Over the next three years, the Company intends to expand its activities to other locations throughout the UK that demonstrate similar characteristics to those currently identified in the North West of England, such as in Yorkshire and the East and West Midlands. The Group will be involved in the full life-cycle of a property development, which includes: the acquisition of land or existing property; obtaining any required revisions to existing planning permission; undertaking development or refurbishment to deliver a high-quality living space; disposal of developed or refurbished property to investors; and provision of L&PFM services to those investors and to other owners of self-contained apartments or Co-living accommodation. The Group employs experienced development and letting professionals, and where appropriate supplements this experience with external providers.  The structure of the business is intended to establish an alignment of interest with the Company's stakeholders that will ultimately drive a growing, stable income for shareholders. Where the Group undertakes development or refurbishment on its own account, income will be derived from: profit made on the disposal of completed properties; and management fees from the provision of L&PFM services to investors who acquire the properties. Where development and refurbishment works are carried out on behalf of third-party investors, additional income will be derived from: initial fees for sourcing and structuring land and property acquisitions; development and refurbishment management fees during the period of building works; and a profit share on disposal of the completed properties. The expectation is that the Group will leverage its marketing network in Hong Kong to pre-sell a significant number of units. This will de-risk the exit and improve the ability of the Group to secure debt finance where this is considered beneficial in improving risk-adjusted returns.  The Directors believe that this strategy will enable the Group to establish a strong market position, and with its in-house capabilities, to generate new business opportunities.  The Directors are focused on establishing the Group as a recognised provider of innovative and high-quality residential developments in the UK and to increase shareholder value (measured in terms of profitability, dividend income or increased share price), in the medium to long term. Board of Directors and Key Management Team The Company's board of directors is comprised of David Stewart Izett, Jeffrey Ian Pym, Jason David Upton, and Yiu Tak (Peter) Cheung. David Stewart Izett is the Non-Executive Chairman and is a fellow of The Royal Institution of Chartered Surveyors with more than 40 years' experience of the real estate industry both in the UK and internationally. Jeffrey Ian Pym is a Non-Executive Director who will chair the Audit and Risk Committee being a qualified Chartered Accountant and highly experienced Chief Financial Officer with over 25 years' experience of the real estate industry. Both have experience of working in companies that have been listed on the London Stock Exchange.  Jason David Upton is the Chief Executive Officer and Peter Cheung is the Chief Investment Officer, both of whom are the founders of the Group's business in the UK, with Peter Cheung being a founder of One Heritage in Hong Kong and a significant shareholder in the Company. The Executive Management Team also includes Peter Child who leads the Group's lettings business, and has over 30 years of experience in the real estate industry; Martin Crews, who is Development Director, with over 10 years of experience in property development; and Markus Luke Piggin, who is a qualified Chartered Accountant, a CFA Charterholder and is the Group's Finance Director. Markus Luke Piggin has previous listed company experience in a senior finance role. Jason Upton, Chief Executive Officer, commented "We are excited to bring One Heritage to the market. We were oversubscribed from a wide range of investors, which represents a real vote of confidence in the potential for the business. We are excited to be one of the first publicly listed residential developers that also focuses on Co-Living, a growing sector with real promise. We see the North West as being a continued centre of growth in the UK in the coming years as the Government invests in levelling up the regions and continues to invest in infrastructure. We believe that we can create a lot of value in the residential market and are excited to part of the solution to tackling the UK's shortage of quality accommodation."   Contacts One Heritage Group plc Jason Upton Chief Executive Officer Email: [email protected]   Luke Piggin Finance Director Email: [email protected]     Hybridan LLP (Adviser and Broker) Claire Louise Noyce Email: [email protected] Tel: +44 (0)203 764 2341

ISIN:	GB00BLF79495
Category Code:	MSCH
TIDM:	OHG
Sequence No.:	90187
EQS News ID:	1157000

 

 

 

End of Announcement	EQS News Service

 

Close

×

RNS Number : 9924I

ZAIM Credit Systems PLC

18 December 2020

 

Not for release or distribution, directly or indirectly, within, into or in the United States or to or for the account or benefit of persons in the United States, Australia, Canada, Japan or any other jurisdiction where such offer or sale would violate the relevant securities laws of such jurisdiction

 

For Immediate Release  18 December 2020

Zaim Credit Systems Plc

("Zaim" or the "Group")

New website launch

 

Zaim Credit Systems plc (the 'Group' or 'Zaim'), the Russian focused fintech group providing financial inclusion for those consumers who are not well served by mainstream lenders, is pleased to announce the launch of the new Group website available at the existing address www.zaimcreditsystemsplc.com .

 

"The launch of the new website is another step aimed to increase  transparency for our existing and potential investors. Our primary goal during the redesign process was to create a more valuable, user-centric and responsive resource across all platforms and devices" – noted Siro Cicconi, Zaim's CEO.

 

Enquiries:

Zaim Credit Systems Plc
Simon Retter Siro Cicconi	Tel: +44 (0) 73 9377 9849
Alex Boreyko	Tel: +7 925 708 98 16 [email protected]
Beaumont Cornish Limited
Roland Cornish / James Biddle	Tel: +44 (0) 20 7628 3396
Optiva Securities Limited
Jeremy King / Vishal Balasingham	Tel: +44 (0) 20 3137 1902

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCGPGCPPUPUURM

Close